# The justices turned away appeals by Novo Nordisk, AstraZeneca, ‌Janssen Pharmaceuticals, Bristol Myers Squibb, Novartis ‌and Boehringer Ingelheim.

*biotech · news · 2026-05-18 · U.S. News & World Report*

## Key points

- The Supreme Court declined to hear drugmakers' challenge to Medicare drug price negotiations.
- Novo Nordisk, AstraZeneca, and other companies argued the plan violates constitutional protections.
- Lower courts had already rejected legal claims against the Inflation Reduction Act's price negotiation mandate.
- Despite lawsuits, Medicare's negotiated prices on 10 drugs went into effect this year.
- The mandatory negotiation requires drugmakers to comply or withdraw all drugs from Medicare programs.

**Companies:** AstraZeneca, Bristol Myers Squibb, Novartis, Novo Nordisk, Janssen Pharmaceuticals, Boehringer Ingelheim
**Countries:** United States, Denmark, Germany

[Read the full story on U.S. News & World Report](https://www.usnews.com/news/top-news/articles/2026-05-18/us-supreme-court-rebuffs-pharma-challenge-to-biden-era-drug-price)

---

Canonical: https://newsio.io/n/2822da53-264c-4ea0-8dae-3f9ebde2cf11/the-justices-turned-away-appeals-by-novo-nordisk-astrazeneca-janssen-pharmaceuti
Summarized by Newsio from U.S. News & World Report. https://newsio.io/how-it-works